Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Non-Current Deferred Tax Liability (2022 - 2025)

Historic Non-Current Deferred Tax Liability for Cartesian Therapeutics (RNAC) over the last 4 years, with Q3 2025 value amounting to $16.1 million.

  • Cartesian Therapeutics' Non-Current Deferred Tax Liability rose 181.67% to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.1 million, marking a year-over-year increase of 181.67%. This contributed to the annual value of $16.1 million for FY2024, which is 6333.51% down from last year.
  • Latest data reveals that Cartesian Therapeutics reported Non-Current Deferred Tax Liability of $16.1 million as of Q3 2025, which was up 181.67% from $16.1 million recorded in Q2 2025.
  • In the past 5 years, Cartesian Therapeutics' Non-Current Deferred Tax Liability ranged from a high of $44.0 million in Q4 2023 and a low of $3.3 million during Q4 2022
  • Moreover, its 4-year median value for Non-Current Deferred Tax Liability was $16.1 million (2024), whereas its average is $17.7 million.
  • In the last 5 years, Cartesian Therapeutics' Non-Current Deferred Tax Liability skyrocketed by 125247.31% in 2023 and then plummeted by 6333.51% in 2024.
  • Quarter analysis of 4 years shows Cartesian Therapeutics' Non-Current Deferred Tax Liability stood at $3.3 million in 2022, then skyrocketed by 1252.47% to $44.0 million in 2023, then plummeted by 63.34% to $16.1 million in 2024, then changed by 0.0% to $16.1 million in 2025.
  • Its Non-Current Deferred Tax Liability was $16.1 million in Q3 2025, compared to $16.1 million in Q2 2025 and $16.1 million in Q1 2025.